HomeOpen Access NewsMedical Treatment

Medical Treatment

Could nasal sprays replace needles for adrenaline delivery in anaphylaxis

A new systematic review shows that nasal spray adrenaline (via liquid or powder sprays) can be as fast or faster than injections for treating anaphylaxis, a possible needle-free alternative to EpiPen®.

Diabetes and rationing in the UK

Jenny Hirst MBE, Co-Chair, highlights the charitable work involved at InDependent Diabetes Trust to support people living with diabetes in the UK.

Everything you need to know about PCOS

The NHS reports that 1 in 5 women in the UK are currently affected by PCOS, but what do we really know about the condition? It’s imperative that women have a clear understanding of their reproductive health. here, we explain everything you need to know about PCOS.

Welsh project aims to offer treatment as ovarian cancer cases continue to rise

A new £2.6 million project led by Swansea University Medical School aims to dramatically improve the diagnosis and treatment of ovarian cancer.

Recovery-focused mental healthcare

Jaime Essed, Founder and CEO of the company Oh My Mood, turns the spotlight onto Recovery-focused mental healthcare.

Precision medicine: Cost-effectiveness of breakthrough treatments

Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.

Medication management in diabetes

PillTime Ltd highlights the importance of medication management for diabetes as it remains a significant burden on the NHS.

Government to invest over £130 million in new NHS technology

Patients will benefit from significant government investment in new NHS technology to improve treatment, diagnosis and care options for diseases including cancer.

The hunt for an alternative to century-old Type 1 diabetes treatment

Dr Elizabeth Robertson, Director of Research at Diabetes UK details the hunt for an alternative to century-old Type 1 diabetes treatment – and looks at how British diabetes research is demanding something better.

New test could diagnose ovarian cancer up to two years earlier

A new test developed at Queen's University could allow ovarian cancer to be diagnosed at a stage up to two years earlier than current methods.

Drug to stop Haemophilia bleeds available on the NHS

NHS England will fund treatment for thousands of people with severe Haemophilia, which will lessen the risk of life-threatening Haemophilia bleeds and reduce treatment time.

Diabetes focus: The role of nutraceuticals in preventing illness

Pete Tate, CEO and Founder of MedTate, explains the role of nutraceuticals in preventing illness when it comes to diabetes in the UK.

NHS could save £727 million if type 2 diabetics met treatment targets

Research from the Nuffield Department of Population Health, University of Oxford, supported by Diabetes UK, has shown that helping people with Type 2 diabetes to meet their three treatment targets could lead to significant savings for the NHS.

A devastating cancer: The priorities for brain tumour research

Chief Executive of Brain Tumour Research, Sue Farrington Smith MBE, outlines the priorities for research into brain tumours and why it is imperative we overcome this uniquely devastating cancer.

Intramembrane proteases in neurodegenerative diseases

Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.

Infection prevention: Overcoming challenges in sepsis diagnosis

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group discusses the concerns with overcoming challenges in sepsis diagnosis.

Diabetes UK appoints twenty new Clinical Champions

Diabetes UK has appointed twenty healthcare professionals, including consultants, nurses, GPs, dietitians, podiatrists, pharmacists and psychologists as its newest cohort of Clinical Champions.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders